What Nobody Tells You About Ozempic and Type 2 Diabetes

By: Ray Taylor

Your doctor offers you a shot. Lower A1C. Lose weight. One injection a week. Done.

That is the pitch. The ads make the pitch. The waiting-room posters make the pitch. The nurse who hands you the prescription makes the pitch.

This post is the part of the conversation nobody else is having with you. What the drug actually does inside your body. What happens when you stop. Why the body rebounds. And a real, honest acknowledgment of the one place these drugs have shown up with a measurable win.

I am not anti-drug. I am not anti-doctor. I am writing this because the version of the story you get from a 30-second commercial is not the whole story. I am giving you the rest of it.

What the drug actually does

GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound are not magic. They are powerful medications that hijack your body’s natural gut hormone signals to force four things.

One. They push your pancreas to release more insulin when sugar is high. Over time, that drives your pancreas harder. Your pancreas was already struggling. Now you are leaning on it more.

Two. They block your liver from releasing its stored sugar. That is one of your body’s normal safety mechanisms. When you block it, you make yourself more vulnerable to dangerous blood sugar crashes.

Three. They paralyze your stomach muscles to slow digestion. Food sits in your gut longer than it should. You feel full because nothing is moving. That is not the same as being nourished. Some people land in the hospital because of this. Look up gastroparesis. It is a real word and it shows up in a real lawsuit (MDL 3094, ongoing). Nothing is proven yet. That does not mean the signal is nothing.

Four. They mess with the appetite signals in your brain. Hunger goes quiet. You eat less because the part of you that says “I am hungry” got turned down. You did not learn to eat less. The drug just took your hunger away.

That is the mechanism. That is not a healing process. That is a chemical override of four different body systems.

In my book I called it painting a car with a bad engine. The car looks better. The engine is still bad. Sooner or later, it breaks down.

What happens when you stop

This is the part the commercials skip.

About 53% of all GLP-1 users stop taking the drug within a year. For people prescribed it specifically for weight loss, that number is closer to 65%. (Source: Truveta, 2024 preprint on real-world discontinuation patterns.) A separate Blue Cross analysis found 58% quit before they even hit a clinical benefit. Read that twice. Most people who start the shot do not finish a year on it.

What happens when they stop? In the STEP-1 trial extension (Wilding et al., 2022), participants regained about two-thirds of the weight they had lost within a year of stopping. Eleven point six pounds of every seventeen-point-three pounds lost came back. Most people land lower than where they started, but the climb back is real.

For Type 2 specifically, this matters even more. The drug does not heal insulin resistance. It does not heal the pancreas. It manages the numbers while it is in your system. When the drug leaves, the underlying problem is still there, often worse, because you spent twelve months suppressing your appetite rather than learning how to eat. You did not build a new relationship with food. You rented one.

That is the leash. That is the lifelong commitment nobody mentions when they hand you the first month’s sample.

The muscle problem

The trials are honest about this part if you read the fine print. They just do not put it on TV.

When you lose weight on a GLP-1, about 25 to 40% of what you lose is lean tissue, including skeletal muscle. In the biggest trials (STEP-1 for semaglutide, SURMOUNT-1 for tirzepatide), the muscle loss percentage came in closer to a quarter of total weight lost. Some studies report higher.

Why does this matter for a Type 2 reader?

Skeletal muscle is roughly 80% of where your body parks blood sugar after a meal. (See DeFronzo’s work on insulin-stimulated glucose disposal. This is well established.) Your muscle is the glucose sponge. The more muscle you have, the more places your blood sugar has to go. Lose muscle, and you are shrinking the sponge.

So the drug lowers your A1C while you are on it. But every week, it is also chipping away at the tissue that was helping you regulate blood sugar on your own. The day you stop the shot, you are not the same body you were before. You are a smaller, weaker version of that body, and your glucose disposal machinery is smaller, and your appetite is coming back.

This is the part I cannot get past. The drug fixes the number while making the system that produces the number worse.

The honest part

I want to be straight with you because I trust you with the truth.

In one large trial (SELECT, NEJM 2023), semaglutide in adults with established cardiovascular disease and overweight or obesity showed a 20% reduction in major cardiovascular events over about three years. Heart attacks, strokes, cardiovascular death. That is a real result in a real population, and it deserves to be on the table.

If you have established heart disease, a real conversation with a real cardiologist about whether semaglutide makes sense for YOUR specific situation is a reasonable conversation. I am not standing in the way of that.

What I am standing in the way of is the version where a brand-new Type 2 patient with no cardiovascular event in their history gets a shot pushed on them as a default first move, with no plan, no education, no exit ramp, no discussion of food or movement or sleep, and no honest description of what happens when they eventually stop.

That is not medicine. That is a transaction.

What I did instead

Eight LabCorp draws over four years. From 11.7 in July 2022 to 5.5 in March 2026. Zero Ozempic. Zero metformin in my body today. Zero surgery. Zero shots.

I did three things, all of them free, all of them boring, all of them yours to keep when the work is done.

Real food. I cut the processed stuff. I added fish, eggs, nonfat plain Greek yogurt, cottage cheese, chickpeas, walnuts, pumpkin seeds, berries, leafy greens, olive oil, avocado. Plant-forward. Flexible. Mine. I call it “Kinda Vegan, Kinda Not.”

A shorter eating window. I learned the simple truth that nobody teaches in school. When you stop eating for stretches of time, your insulin gets to rest. Your liver gets to clear stored sugar. The body starts listening to its own signals again. The drug paralyzes your stomach to fake fullness; fasting just gives the stomach time off.

Walking. Cheap. Free, actually. I walked. A lot. Your muscles open a door called GLUT4 and they pull sugar out of your blood without any extra insulin. A 30 minute walk after a meal can change your number on a meter in the same hour. I have done it hundreds of times. It works.

None of those three pillars chip away at your muscle. None of them have a discontinuation rate. None of them carry a black-box warning. None of them stop working the day you stop them, because they ARE the lifestyle, not a chemical intervention on top of it.

That is the choice. Drug-managed numbers with a leash, or lifestyle-driven numbers that are yours.

If you want the cleanest possible on-ramp, I packaged the first 24 hours of the protocol into a free guide. It is the gentle window I lay out for new readers. Not extreme. Not OMAD. Just enough to feel the difference in one day.

Get the 24 Hour Reset → divorcediabetes.com/start/

If you want the full story of how the lab arc landed, the longer read lives here: How I Dropped My A1C From 11.7 to 5.5 Without Ozempic. The deepest version with every dated draw is at a1c-5-5-where-i-am-now.

The whole book lays it out: Type 2 Ain’t My Type on Amazon.

Consistent persistence overcomes resistance. Every. Single. Time.

This is not medical advice. Do not change your medication without your doctor.

As an Amazon Associate I earn from qualifying purchases.